Let the assistant research this device
The Research Assistant compiles risk class, certificates, notified bodies and related records — and cites every one.
Free to try · every answer cites its records
Basic Information
- Primary DI
- D-6430030990585UL
- Basic UDI-DI Code
- B-6430030990585UL
- Reference
- 31931RETAL
- Device Types
-
Single use
- Regulation
- Eu Ivdd
- Classification
- Eu Ivd General
- Status
- On The Market
- Manufacturer
- Actim Oy
Additional Description
10 test kit. Actim® Partus 1ngeni test is a qualitative immunochromatographic dipstick test for detecting the presence of phosphorylated IGFBP-1 (insulin-like growth factor binding protein-1) in cervical secretions during pregnancy. The test is read using the Actim® 1ngeni instrument. The test is intended for professional use to help predict the risk of preterm or imminent delivery when fetal membranes are intact. A low risk test result (phIGFBP-1 concentration less than 10 µg/l) is a clear indication that the patient is not likely to deliver within 7-14 days.
CND Nomenclature Codes
| Code | Description |
|---|---|
| W01021699 | RAPID TESTS & POINT OF CARE - IMMUNOCHEMISTRY - OTHER |
Available In Countries
Similar Devices
Other on-the-market devices with the same classification (Eu Ivd General) and regulation (EU IVDD).